Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Genpharmasec Financial Results

Genpharmasec approved unaudited half-year results and planned sale of its wholly owned subsidiary Clinigenome India. Company Secretary Hardik Makwana resigns effective 16 November 2026.

Source

BSE filing, NSE: ADIRASA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Genpharmasec Ltd: key numbers

Share price
₹1.04
Market cap
₹57.59 Cr
Revenue (annual)
₹139.9 Cr
Net profit (annual)
₹1.60 Cr
P/E (TTM)
-472.7×Sector 47.2×
Promoter holding
32.06%+2.08% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Genpharmasec Ltd

All →

Other financial results announcements

All →
19:26 IST NSE
Financial ResultsSubex Ltd SUBEXLTD

Subex Q2 FY27 Results: Net Profit ₹14.3 Cr, Up 393.1% YoY

Subex Ltd reported revenue from operations of ₹85.6 Cr (+24.2% YoY) and net profit of ₹14.3 Cr (+393.1% YoY) for Q2 FY27.

Key figure
Net profit ₹14.3 Cr · +393.1% YoY